Short term Caco-2/TC7 cell culture: Comparison between of conventional 21-d and a commercially available 3-d system

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 12, 2004, Pages 1986-1992

  Da Violante, Georges ^a   Zerrouk, Naima ^a   Richard, Isabelle ^b   Frendo, Jean Louis ^c   Zhiri, Azzédine ^b   Li Khuan, René ^d   Tricottet, Viviane ^d   Provot, Gérard ^b   Chaumeil, Jean Claude ^a   Arnaud, Philippe ^d  

^a UNIV PARIS SUD   (France)

^b GLAXOSMITHKLINE   (France)

^c INSERM   (France)

^d FACULTÉ DES SCIENCES PHARMACEUTIQUES ET BIOLOGIQUES   (France)

Author keywords

Apparent permeability; Caco 2 TC7; CYP450; Lactate dehydrogenase; Morphology; Phosphatase alkaline

Indexed keywords

ALKALINE PHOSPHATASE; CYTOCHROME P450; HYDROLASE; LACTATE DEHYDROGENASE; MANNITOL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; COMPARATIVE STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGING SYSTEM; INTESTINE ABSORPTION; INTESTINE CELL; LACTATE DEHYDROGENASE BLOOD LEVEL; MONOLAYER CULTURE; REAL TIME POLYMERASE CHAIN REACTION; THREE DIMENSIONAL IMAGING; TRANSMISSION ELECTRON MICROSCOPY; CULTURE TECHNIQUE; METABOLISM; METHODOLOGY; PHYSIOLOGY; TIME; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL CULTURE TECHNIQUES; CELL MEMBRANE PERMEABILITY; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; INTESTINAL ABSORPTION; TIME FACTORS;

EID: 21644489142     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1986     Document Type: Article

References (23)

1. Artursson P., J. Pharm. Sci., 79, 476-482 (1990).
2. Artursson P., Karlsson J., Biochem. Biophys. Res. Commun., 175, 880-885 (1991).
3. Irvine J. D., Takahashi L., Lockhart K., Cheong J., Tolan J. W., Selick H. E., Grove J. R., J. Pharm. Sci., 88, 28-33 (1999).
4. Pontier C., Pachot J., Botham R., Lenfant B., Arnaud P., J. Pharm. Sci., 90, 1608-1619 (2001).
5. Engle M. J., Goetz G. S., Alpers D. H., J. Cell. Physiol., 174, 362-369 (1998).
6. Raeissi S. D., Guo Z., Dobson G. L., Artursson P., Hidalgo I. J., Pharm. Res., 14, 1019-1025 (1997).
7. Raeissi S. D., Hidalgo I. J., Segura-aguilar J., Artursson P., Pharm. Res., 16, 625-632 (1999).
8. Caro I., Boulenc X., Rousset M., Meunier V., Bourrié M., Julian B., Joyeux H., Roques C., Berger Y., Zweibaum A., Fabre G., Int. J. Pharm., 116, 147-158 (1995).
9. Chong S., Dando S. A., Morrison R. A., Pharm. Res., 14, 1835-1837 (1997).
10. Lentz K. A., Hayashi J., Luciano L. J., Polly J. E., Int. J. Pharm., 200, 41-51 (2000).
11. Liang E., Chessic K., Yazdanian M., J. Pharm. Sci., 89, 336-345 (2000).
12. Yamashita S., Konishi K., Yamazaki Y., Taki Y., Sakane T., Sezaki H., Furuyama Y., J. Pharm. Sci., 91, 669-679 (2002).
13. Collett A., Sims E., Walker D., He Y.-L., Ayrton J., Rowland M., Warhurst G., Pharm. Res., 13, 216-221 (1996).
14. Eicholtz A., Biochi. Biophys. Acta, 135, 39-49 (1967).
15. Pollard H. B., Menard R., Brandt H. A., Pazoles C. J., Creutz C. E., Ramu A., Anal. Biochem., 86, 761-763 (1978).
16. Hidalgo I. J., Borchardt R. T., Biochim. Biophys. Acta, 1028, 25-30 (1990).
17. Lee C.-P., de Vrueh R. L. A., Smith P. L., Adv. Drug Del. Rev., 23, 47-62 (1997).
18. Chantret I., Barbat A., Dussaulx E., Brattain M. G., Zweibaum A., Cancer Res., 48, 1936-1942 (1998).
19. Engman H. A., Lennernas H., Taipalnsiuu J., Otter C., Leidvik B., Artursson P., J. Pharm. Sci., 90, 1736-1751 (2001).
20. Hu M., Borchardt T., Pharm. Res., 7, 1313-1319 (1990).
21. Cogburn J. N., Donovan M. G., Schasteen C. S., Pharm. Res., 8, 210-216 (1991).
22. Delie F., Rubas W., Crit. Rev. Ther. Drug Car. Syst., 14, 221-286 (1997).
23. Amidon G. L., Lennernäs H., Shah V. P., Crison J. R., Pharm. Res., 12, 413-420 (1995).